CytomX Therapeutics, Inc. (CTMX) Total assets 2016–2025
CytomX Therapeutics, Inc. (CTMX) total assets at each fiscal year-end, per SEC filings.
$151.6MFY2025 · since FY2016: $199.1M → $151.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $151.6M | +25.7% |
| FY2024 | $120.5M | -40.3% |
| FY2023 | $201.8M | -22.7% |
| FY2022 | $260.9M | -23.1% |
| FY2021 | $339.4M | -5.4% |
| FY2020 | $358.7M | +5.1% |
| FY2019 | $341.3M | -25.3% |
| FY2018 | $457.1M | +15.0% |
| FY2017 | $397.6M | +99.7% |
| FY2016 | $199.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTMX financial trends
CTMX RevenueCTMX Net incomeCTMX Net marginCTMX Gross profitCTMX Gross marginCTMX Operating incomeCTMX Operating marginCTMX Operating cash flowCTMX Free cash flowCTMX Capital expendituresCTMX Return on equityCTMX Stock buybacksCTMX Dividends paidCTMX Total liabilitiesCTMX Shareholders’ equityCTMX overview →